Keystone Symposium: Neurodegenerative Diseases: New Molecular Mechanisms
I was at this symposium very recently and got to hear very nice talks. The focus on the talk was mostly AD and HD and less emphasis on PD. The quality of presentations and the posters were very nice and of high scientific depth.
Several pharmaceutical companies were interested in LRRK2 poster of mine: looks like LRRK2 has been out there as a very attractive therapeutic drug target. And being a kinase, it attracts people very much to invest and investigate in order to arrive at a putative inhibitor.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment